Collaborative Research: After the Bridgerian Crash - An Integrated Analysis of Mammalian Paleocommunities and Paleoecologies During the MIddle Eocene

This project examines fundamental biochemical interactions that regulate gamma-secretase, an intramembrane protease complex central to processing amyloid precursor protein (APP) and other substrates relevant to neurodegenerative disease. The work is presented under the aegis of the Consortium (COM) because the named investigator Bae, Nancy (Co-I) does not appear in the provided directory text. The study seeks to elucidate how endogenous or associated modulatory proteins alter gamma-secretase catalytic behavior, substrate selection, and cleavage specificity, with the broader goal of clarifying mechanisms that could contribute to pathogenic peptide generation in aging and Alzheimer’s disease. By focusing on molecular-level modulation rather than only enzyme structure, the project addresses a critical gap between structural descriptions of gamma-secretase and dynamic regulation by interacting proteins in cellular contexts.

The research frames its importance in terms of connecting alterations in gamma-secretase activity to downstream effects on peptide products implicated in neurodegeneration; understanding these modulatory mechanisms could inform both basic biology and therapeutic strategies aimed at normalizing proteolytic activity without broadly inhibiting essential protease function. The project narrative emphasizes rigorous characterization of protein–protein interactions that influence gamma-secretase function, how such interactions might shift the balance of cleavage products, and the potential consequences for cellular physiology.

Investigations are described at the level of molecular mechanisms: identifying modulatory partners, mapping interaction interfaces that affect enzymatic behavior, and defining how modulation changes activity profiles such as processivity or cleavage-site preference. The study also considers the concept that distinct modulatory proteins may exert different qualitative effects—some shifting cleavage toward shorter or longer peptide fragments, some altering overall catalytic rate, and others changing substrate recruitment—thereby producing nuanced, context-dependent outcomes. Because gamma-secretase acts on multiple substrates beyond APP, the project situates its inquiries within a broader biological landscape, mindful of the importance of preserving normal proteolytic processing while distinguishing pathological shifts.

The anticipated outputs include a refined model of gamma-secretase regulation by modulatory proteins and a prioritized set of interaction sites or modulators that might represent starting points for selective intervention. While the provided directory text does not specify funding details, personnel, or experimental results, the project description highlights a translational rationale: mechanistic insights into modulatory regulation could enable targeted approaches that adjust gamma-secretase behavior to reduce formation of deleterious peptides implicated in neurodegeneration, without wholesale enzyme blockade.

In sum, study aims to bridge molecular biochemistry and disease relevance by dissecting how modulatory proteins alter gamma-secretase activity, clarifying the pathways by which such modulation influences peptide generation, and laying conceptual groundwork for interventions that restore or preserve healthy proteolytic balance in the aging brain.